1. Home
  2. AFMD vs LIQT Comparison

AFMD vs LIQT Comparison

Compare AFMD & LIQT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AFMD
  • LIQT
  • Stock Information
  • Founded
  • AFMD 2000
  • LIQT 2004
  • Country
  • AFMD Germany
  • LIQT Denmark
  • Employees
  • AFMD N/A
  • LIQT N/A
  • Industry
  • AFMD Biotechnology: Pharmaceutical Preparations
  • LIQT Industrial Machinery/Components
  • Sector
  • AFMD Health Care
  • LIQT Technology
  • Exchange
  • AFMD Nasdaq
  • LIQT Nasdaq
  • Market Cap
  • AFMD 14.5M
  • LIQT 16.9M
  • IPO Year
  • AFMD 2014
  • LIQT N/A
  • Fundamental
  • Price
  • AFMD $0.72
  • LIQT $1.62
  • Analyst Decision
  • AFMD Strong Buy
  • LIQT Strong Buy
  • Analyst Count
  • AFMD 5
  • LIQT 2
  • Target Price
  • AFMD $13.50
  • LIQT $4.60
  • AVG Volume (30 Days)
  • AFMD 86.2K
  • LIQT 8.0K
  • Earning Date
  • AFMD 04-08-2025
  • LIQT 03-28-2025
  • Dividend Yield
  • AFMD N/A
  • LIQT N/A
  • EPS Growth
  • AFMD N/A
  • LIQT N/A
  • EPS
  • AFMD N/A
  • LIQT N/A
  • Revenue
  • AFMD $6,287,085.00
  • LIQT $14,604,618.00
  • Revenue This Year
  • AFMD N/A
  • LIQT N/A
  • Revenue Next Year
  • AFMD $225.65
  • LIQT $31.19
  • P/E Ratio
  • AFMD N/A
  • LIQT N/A
  • Revenue Growth
  • AFMD N/A
  • LIQT N/A
  • 52 Week Low
  • AFMD $0.70
  • LIQT $1.34
  • 52 Week High
  • AFMD $8.95
  • LIQT $3.20
  • Technical
  • Relative Strength Index (RSI)
  • AFMD 30.95
  • LIQT 47.22
  • Support Level
  • AFMD $0.85
  • LIQT $1.50
  • Resistance Level
  • AFMD $0.89
  • LIQT $1.72
  • Average True Range (ATR)
  • AFMD 0.05
  • LIQT 0.06
  • MACD
  • AFMD -0.01
  • LIQT 0.02
  • Stochastic Oscillator
  • AFMD 22.75
  • LIQT 37.84

About AFMD Affimed N.V.

Affimed NV is a clinical-stage biopharmaceutical company. The company is engaged in discovering and developing targeted cancer immunotherapies. Its product candidates are being developed in the field of immuno-oncology, which represents an approach to cancer treatment that seeks to harness the body's immune defenses to fight tumor cells. It is active in the discovery, pre-clinical and clinical development of antibodies based on its core technology. The Company generates revenues from the provision of research and development services to third parties based on both Group and third party owned intellectual property. Geographically, it derives a majority of revenue from the United States and also has a presence in and Germany.

About LIQT LiqTech International Inc.

LiqTech International Inc is a clean technology company which provides technology for gas and liquid purification by manufacturing ceramic silicon carbide filters. The company is engaged in three businesses that are diesel particulate filters (DPF) for the control of soot from diesel engines, turnkey ceramic membranes systems, and complete water treatment plants. The company's product portfolio consists of ceramic silicon membranes for liquid filtration, diesel particulate filters, and kiln furniture. Its operating segment includes Water, Ceramics, and Plastics.

Share on Social Networks: